The mRNA level of SLC40A1 was significantly higher in glioma tissues than normal tissues in a comprehensive dataset (TCGA-GBM plus TCGA-LGG), and the expression of SLC40A1 increased with an increase in tumor grade (Supplementary Fig. 5A, B). This evidence concerns the gene SLC40A1 and central nervous system cancer.